Trial Design Innovation In Clinical Drug Development Conference, 15-16 November 2012, Philadelphia, PA
Conference organizer ExL Pharma is proud to bring the Trial Design In Clinical Drug Development Conference to the Loew’s Hotel in Philadelphia, PA on November 15-16, 2012. The mission is to bring to light the current status of the use of Trial Design Innovations in practice, share technology enhancements used for protecting trial integrity including the role of simulations, and examine the effect that FDA Draft Guidance has had on industry.
With the industry determined to bring new drugs to market faster, despite the increasing complexity of clinical trials, there is a strong need to share current practices of adaptive trial design, as well as leverage technology to protect trial integrity.
Currently the industry is buzzing with case studies, technological advances, simulations, books, lectures, webinars and other resources virtually everywhere on Adaptive Trial Design. During this interactive learning experience, attendees will learn from industry professionals together through the case studies, panels, and a workshop on “Project Management – Effective Implementation and Management of Adaptive Trials from an Operational Perspective”. Because of the growing use of technology and simulations that are becoming available to the life science industry, Adaptive Trial Design is the main way to modify aspects of the study as it continues, without undermining the validity of the trial.
The conference will focus on FDA Draft Guidance and the impact on the industry, as well as better technology to protect trial integrity. The conference will also look into strategies for successful implementation of adaptive designs in drug development and the effective implementation and management of adaptive trials from an operational perspective.
ExL Pharma, a division of ExL Events, Inc., is the industry leader in developing innovative, educational conferences that serve the pharmaceutical and allied healthcare communities in the United States, Europe, Latin America and various markets. Behind our diverse pharmaceutical event portfolio, ExL’s experienced team conducts extensive market research and targeted outreach. The results translate into innovative, high-quality events designed to exceed the dynamic informational and networking needs of specific audiences and working groups.
ExL Pharma conference platforms facilitate the exchange of critical information between industry executives and suppliers who support their scientific and commercial goals. Our events are the preferred resource for industry professionals seeking important information and networking opportunities with a clear delineation between content and commercialism.